Skip to main content
Caplight Logo









Pinecone Therapeutics

Pinecone Therapeutics

Private
United StatesHealthcare & Life Scienceshttps://pineconetx.com

Last Round

Accelerator

Nov 6, 2025

Company Overview

Pinecone Therapeutics is a biotechnology company that develops one-time gene therapies for severe, inherited metabolic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine

Business Model

B2B2C

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

gene therapyPropionic Acidemiaone-time gene therapyrare disease therapyinherited metabolic disordersclinical-stage biotechgenetic medicinedisease-modifying therapycell and gene therapyCGTpediatric rare diseaseinborn errors of metabolismtranslational science

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pinecone Therapeutics Comparables

Compare Pinecone Therapeutics with similar companies based on industry and business-model similarity.

Pinecone Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AstraZeneca
77%
HemoShear Therapeutics
77%
Moderna, Inc.
75%

Pinecone Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorNov 6, 2025

Pinecone Therapeutics Investors

Notable investors and investment history

Pinecone Therapeutics investors
InvestorRounds
Deerfield ManagementAccelerator
Cure by DeerfieldAccelerator
Qatar Development BankAccelerator
Qatar Investment AuthorityAccelerator

Pinecone Therapeutics Filings

Explore SEC and related filing metadata, where available.

Pinecone Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pinecone Therapeutics's valuation, stock price, and market status.

Is Pinecone Therapeutics a public or private company?

Pinecone Therapeutics is a private company.

What is the current stock price of Pinecone Therapeutics?

Pinecone Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Pinecone Therapeutics worth (valuation)?

Valuation information for Pinecone Therapeutics is not publicly available.

Can I buy Pinecone Therapeutics stock?

Pinecone Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pinecone Therapeutics's last funding round?

Funding round information for Pinecone Therapeutics is not publicly available.

Who are the main investors in Pinecone Therapeutics?

Investor information for Pinecone Therapeutics is not publicly disclosed.

Will Pinecone Therapeutics IPO soon?

No public IPO plans have been announced for Pinecone Therapeutics.

How can I track Pinecone Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pinecone Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersUnited States
Year FoundedN/A
Last FundingNov 6, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?